1.Date of the shareholders' meeting resolution:2026/05/27

2.Name and title of the managerial officer with permission to engage in competitive conduct:
(1)TTY Biopharm Company Limited;Director (2)Representative of TTY Biopharm Company Limited:Chuan Lin;Director (3)Representative of TTY Biopharm Company Limited:Carl Hsiao;Director (4)Representative of TTY Biopharm Company Limited:Kang-Chi Chou;Director (5)Duei Tsai；Director
3.Items of competitive conduct in which the officer is permitted to engage:Investing in or operating other companies that engage in the same or similar business scope as the Company.

4.Period of permission to engage in the competitive conduct:The period of being director of the Company.

5.Circumstances of the resolution (please describe the results of voting in accordance with Article 209 of the Company Act):
(1)24,295,724 in total voting rights were represented at the time of voting; (2)24,193,745 voting right presented for, 99.58% of total voting rights; (3)65,221voting right presented against, 0.26% of total voting rights; (4)0 invalid votes,0% of total voting rights; (5)36,758 voting right presented abstention and not voting,0.15% of total voting rights; (6)this proposal was approved as proposed as affirmative rights higher than statutory ones.
6.If the permitted competitive conduct belongs to the operator of a mainland China enterprise, the name and title of the directors (if it is not the operator of a mainland China enterprise, please enter “N/A” below):N/A

7.Company name of the mainland China enterprise and the officer’s position in the enterprise:N/A

8.Address of the mainland China enterprise:N/A

9.Operations of the mainland China enterprise:N/A

10.Impact on the company’s finance and business:N/A

11.If the directors have invested in the mainland China enterprise, the monetary amount of the investment and their shareholding ratio:N/A.

12.Any other matters that need to be specified:None.